Terms: = Sarcomas AND CDK6, MGC59692, 1021, Q00534, ENSG00000105810, PLSTIRE
123 results:
1. Development of a novel six DNA damage response-related prognostic signature in osteosarcoma.
Li T; Tang Z; Li S; Lu M
Cell Mol Biol (Noisy-le-grand); 2024 Mar; 70(3):110-115. PubMed ID: 38650147
[TBL] [Abstract] [Full Text] [Related]
2. CircPRMT5 promotes progression of osteosarcoma by recruiting CNBP to regulate the translation and stability of cdk6 mRNA.
Liu Y; Jiang H; Hu K; Zou H; Zhang W; Liu J; Jian X
PLoS One; 2024; 19(4):e0298947. PubMed ID: 38626179
[TBL] [Abstract] [Full Text] [Related]
3. Vitexicarpin Induces Apoptosis and Inhibits Metastatic Properties via the AKT-PRAS40 Pathway in Human Osteosarcoma.
Yun HM; Kwon HS; Lee JY; Park KR
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612399
[TBL] [Abstract] [Full Text] [Related]
4. Hijacking of nucleotide biosynthesis and deamidation-mediated glycolysis by an oncogenic herpesvirus.
Wan Q; Tavakoli L; Wang TY; Tucker AJ; Zhou R; Liu Q; Feng S; Choi D; He Z; Gack MU; Zhao J
Nat Commun; 2024 Feb; 15(1):1442. PubMed ID: 38365882
[TBL] [Abstract] [Full Text] [Related]
5. The Targeted Therapies for Osteosarcoma
Wang S; Ren Q; Li G; Zhao X; Zhao X; Zhang Z
Curr Mol Pharmacol; 2024; 17(1):e210823220109. PubMed ID: 37602543
[TBL] [Abstract] [Full Text] [Related]
6. CRISPR-Cas9 screening identified lethal genes enriched in necroptosis pathway and of prognosis significance in osteosarcoma.
Cheng L; Xiong W; Li S; Wang G; Zhou J; Li H
J Gene Med; 2023 Dec; 25(12):e3563. PubMed ID: 37421290
[TBL] [Abstract] [Full Text] [Related]
7. Adjuvant Palbociclib May be Associated with Delayed Recurrence in Completely Resected Retroperitoneal Liposarcoma: Results of a Single-Institution Retrospective Cohort Study.
Selby LV; Clark EC; Liebner DA; Chen JL; Tinoco G; Bashian E; Beane JD; Pollock RE; Grignol VP
Ann Surg Oncol; 2023 Nov; 30(12):7876-7881. PubMed ID: 37330448
[TBL] [Abstract] [Full Text] [Related]
8. Parthenolide inhibits proliferation of cells infected with Kaposi's sarcoma-associated herpesvirus by suppression of the NF-κB signaling pathway.
Li Y; Xu H; Tan X; Cui Q; Gu W; Pan Z; Yang L; Wu S; Wang X; Li D
Arch Virol; 2023 Jan; 168(2):39. PubMed ID: 36609933
[TBL] [Abstract] [Full Text] [Related]
9. MicroRNA-15 suppresses viability, migration and invasion of the human MG-63 osteosarcoma cells via inhibition of cyclin dependent kinase 6 (cdk6).
Shen Z; Wang C; Liu B; Du J; Li Z; Zhao J
Acta Biochim Pol; 2022 Oct; 69(4):761-766. PubMed ID: 36272153
[TBL] [Abstract] [Full Text] [Related]
10. A novel immune cell signature for predicting osteosarcoma prognosis and guiding therapy.
Pan R; Pan F; Zeng Z; Lei S; Yang Y; Yang Y; Hu C; Chen H; Tian X
Front Immunol; 2022; 13():1017120. PubMed ID: 36189307
[TBL] [Abstract] [Full Text] [Related]
11. An overview of CDK3 in cancer: clinical significance and pharmacological implications.
Teo T; Kasirzadeh S; Albrecht H; Sykes MJ; Yang Y; Wang S
Pharmacol Res; 2022 Jun; 180():106249. PubMed ID: 35533805
[TBL] [Abstract] [Full Text] [Related]
12. miR-34a-5p inhibits the malignant progression of KSHV-infected SH-SY5Y cells by targeting c-fos.
Wu S; Wu Z; Xu H; Zhang J; Gu W; Tan X; Pan Z; Cao D; Li D; Yang L; Li D; Pan Y
PeerJ; 2022; 10():e13233. PubMed ID: 35444864
[TBL] [Abstract] [Full Text] [Related]
13. Oncogenic lncRNA ZNFX1 antisense RNA 1 promotes osteosarcoma cells proliferation and metastasis by stabilizing serine and arginine‑rich splicing factor 3.
Zhang Y; Xu W; Wang Y; Li J; He G; Guan M; Zeng X; Bian W; Song Y; Liu J
Bioengineered; 2022 Mar; 13(3):5962-5974. PubMed ID: 35184675
[TBL] [Abstract] [Full Text] [Related]
14. Interfering with pak4 Protein Expression Affects Osteosarcoma Cell Proliferation and Migration.
Fu Y; Fang L; Yin Q; Wu Q; Sui W; Sun Y; Zhao X; Wu Y; Zhou L
Biomed Res Int; 2021; 2021():9977001. PubMed ID: 35005025
[TBL] [Abstract] [Full Text] [Related]
15. A murine mesenchymal stem cell model for initiating events in osteosarcomagenesis points to CDK4/cdk6 inhibition as a therapeutic target.
Franceschini N; Gaeta R; Krimpenfort P; Briaire-de Bruijn I; Kruisselbrink AB; Szuhai K; Palubeckaitė I; Cleton-Jansen AM; Bovée JVMG
Lab Invest; 2022 Apr; 102(4):391-400. PubMed ID: 34921235
[TBL] [Abstract] [Full Text] [Related]
16. Intimal sarcomas and undifferentiated cardiac sarcomas carry mutually exclusive MDM2, MDM4, and cdk6 amplifications and share a common DNA methylation signature.
Koelsche C; Benhamida JK; Kommoss FKF; Stichel D; Jones DTW; Pfister SM; Heilig CE; Fröhling S; Stenzinger A; Buslei R; Mentzel T; Baumhoer D; Ladanyi M; Antonescu CR; Flucke U; Gorp JV; Bode-Lesniewska B; Deimling AV; Mechtersheimer G
Mod Pathol; 2021 Dec; 34(12):2122-2129. PubMed ID: 34312479
[TBL] [Abstract] [Full Text] [Related]
17. LncRNA LOC100129620 promotes osteosarcoma progression through regulating cdk6 expression, tumor angiogenesis, and macrophage polarization.
Chen Y; Tang G; Qian H; Chen J; Cheng B; Zhou C; Shen Y
Aging (Albany NY); 2021 May; 13(10):14258-14276. PubMed ID: 34015762
[TBL] [Abstract] [Full Text] [Related]
18. Management of Pediatric Breast Masses: A Multi-institutional Retrospective Cohort Study.
Lawrence AE; Saito J; Onwuka A; Port E; Bowder A; Courtney C; Deans KJ; Downard CD; Duran YK; Fallat ME; Fraser JD; Gadepalli S; Kabre R; Kalbfell EL; Knaus ME; Kohler J; Lal D; Landman MP; Leys CM; Lu P; Mak GZ; Markel T; Merchant N; Nguyen T; Pilkington M; Rymeski B; Sato TT; St Peter SD; Wright T; Minneci PC; Grabowski JE
J Surg Res; 2021 Aug; 264():309-315. PubMed ID: 33845414
[TBL] [Abstract] [Full Text] [Related]
19. Opposing immune and genetic mechanisms shape oncogenic programs in synovial sarcoma.
Jerby-Arnon L; Neftel C; Shore ME; Weisman HR; Mathewson ND; McBride MJ; Haas B; Izar B; Volorio A; Boulay G; Cironi L; Richman AR; Broye LC; Gurski JM; Luo CC; Mylvaganam R; Nguyen L; Mei S; Melms JC; Georgescu C; Cohen O; Buendia-Buendia JE; Segerstolpe A; Sud M; Cuoco MS; Labes D; Gritsch S; Zollinger DR; Ortogero N; Beechem JM; Petur Nielsen G; Chebib I; Nguyen-Ngoc T; Montemurro M; Cote GM; Choy E; Letovanec I; Cherix S; Wagle N; Sorger PK; Haynes AB; Mullen JT; Stamenkovic I; Rivera MN; Kadoch C; Wucherpfennig KW; Rozenblatt-Rosen O; Suvà ML; Riggi N; Regev A
Nat Med; 2021 Feb; 27(2):289-300. PubMed ID: 33495604
[TBL] [Abstract] [Full Text] [Related]
20. Cyclin Pathway Genomic Alterations Across 190,247 Solid Tumors: Leveraging Large-Scale Data to Inform Therapeutic Directions.
Jardim DL; Millis SZ; Ross JS; Woo MS; Ali SM; Kurzrock R
Oncologist; 2021 Jan; 26(1):e78-e89. PubMed ID: 32885893
[TBL] [Abstract] [Full Text] [Related]
[Next]
